TRAINING

𝗣𝗿𝗼𝗳. 𝗞𝗵𝗮𝗹𝗶𝗱 𝗔𝗹-𝗥𝗮𝘀𝗮𝗱𝗶, an eminent researcher and scholar and Director of Oman Genome Program will share real data and experience of using single-cell sequencing in Oman and how it has opened new possibilities for understanding lysosomal acid lipase deficiency (LAL-D) in the Omani population.

Prof. Khalid will present how this advanced technology was used to explore disease-associated cellular and molecular changes at unprecedented resolution.

The webinar will highlight key findings, the clinical and research relevance of the study, and the potential of single-cell approaches to advance rare-disease characterization and precision medicine in the region.

𝗔𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗦𝗽𝗲𝗮𝗸𝗲𝗿
Prof. Khalid Al-Rasadi is a Professor of Biochemistry at College of Medicine and Health Sciences, Consultant Lipidologist at Sultan Qaboos University Hospital, and Director of the Oman Genome Program. He is a leading expert in lipid and lipoprotein disorders, clinical lipidology and cardiovascular research. His work focuses on inherited dyslipidaemias and precision medicine, including application of advanced genomic and single-cell technologies to better understand rare metabolic diseases in Oman.

About the Sponsor:
AD-OMICS is the first and only dedicated single-cell and multi-omics service laboratory in the UAE and GCC, advancing precision medicine across the Middle East. Combining cutting-edge genomic technologies with advanced bioinformatics, AD-OMICS delivers integrated solutions that accelerate biomedical discovery and support personalized, predictive, preventive and data-driven healthcare.
𝗙𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲: https://adomics.ae/